Back to Search
VRISHALI SUMAN, MD
MD
Family Medicine Physician
NPI: 1194202705IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
309755(LA)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD17386(RI)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2016
Research & Publications (20)
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
PMID 19648970·Bone Marrow Transplant·2010
3-trial
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.
PMID 19090009·Cancer·2009
3-trial
Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.
PMID 19349549·J Clin Oncol·2009
3-trial
Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study.
PMID 19487378·J Clin Oncol·2009
3-trial
A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study.
PMID 19060590·Am J Clin Oncol·2008
3-trial
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance.
PMID 18794098·Clin Cancer Res·2008
8-other
Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials.
PMID 18235113·J Clin Oncol·2008
8-other
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy.
PMID 18413808·Mol Cancer Ther·2008
8-other
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
PMID 18250349·J Clin Oncol·2008
3-trial
Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
PMID 18568764·Cancer Invest·2008
6-review
Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen.
PMID 17145182·Breast·2007
2-rct
A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma.
PMID 17551310·Am J Clin Oncol·2007
3-trial
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen.
PMID 17115111·Breast Cancer Res Treat·2007
8-other
Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.
PMID 19065716·J Gastrointest Cancer·2007
3-trial
Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study.
PMID 16520332·Ann Oncol·2006
3-trial
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
PMID 16538529·Breast Cancer Res Treat·2006
2-rct
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.
PMID 16609019·Clin Cancer Res·2006
3-trial
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
PMID 16809727·J Clin Oncol·2006
4-observational
Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.
PMID 16891861·Am J Clin Oncol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 239 CRANSTON ST
PROVIDENCE, RI 02907 - Phone
- (401) 444-0580
Quick Facts
- NPI
- 1194202705
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile